2023 Standards of Care in Diabetes Released
ADA’s Dr Gabbay discusses the top changes to the Standards of Care in Diabetes—2023
Diagnosis & Disease Information
New Guideline on Diabetes-Related Hypoglycemia Management Released
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
Obesity in Adolescence Linked to Type 1 Diabetes in Adulthood
Adolescent obesity is correlated with both adult-onset type 1 diabetes and type 2 diabetes.
Obesity-Associated Microvascular and Macrovascular Complications Among Patients With Diabetes
Investigators examined the effect of obesity on microvascular and macrovascular complications among patients with type 1 or type 2 diabetes.
FDA Clears Smartphone App for Insulin Delivery
The updated t:connect mobile app is the first-ever FDA-cleared smartphone application capable of initiating insulin delivery via iOS and Android operating systems.
FDA Accepts Resubmitted Teplizumab BLA for T1D Delay
Teplizumab is an investigational anti-CD3 monoclonal antibody that has been shown to preserve beta cell function, reducing the need for exogenous insulin.
Provention Bio Resubmits BLA for Teplizumab to Delay Type 1 Diabetes
Teplizumab is an investigational anti-CD3 monoclonal antibody that has been shown to preserve beta cell function, reducing the need for exogenous insulin.
Glycemic Control Reduces Risk of Diabetic Foot Ulcers in Type 1 Diabetes
People with type 1 diabetes are at a higher risk for foot ulcers and amputation. Researchers studied whether glycemic control would reduce the risk.
Insulin Prescriptions Fell for Type 2 Diabetes During Height of COVID-19
Insulin prescriptions fell during the COVID-19 pandemic for adults with type 2 diabetes. Children with type 1 diabetes were much less affected.
Insulin Pump Therapy and Telehealth Support Improves Glycemic Control
Continuous subcutaneous insulin infusion revolutionized insulin delivery for people with type 1 diabetes. Researchers measured several devices and their effects on glycated hemoglobin levels, in addition to telehealth support, over a 3 month period.
- Loading...
Loading...
Next post in Endocrinology
Loading... 
Loading...